India’s Biotech Moment: Eyestem CEO bets on fast-tracked cures & global breakthroughs
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
Subscribe To Our Newsletter & Stay Updated